The CDC’s Advisory Committee on Immunization Practices made a unanimous recommendation for use of meningococcal group B vaccines to vaccinate high-risk groups in the United States.
The Food and Drug Administration is looking into enabling holders of abbreviated new drug applications to unilaterally update their generic drug product labels prior to any branded drug change.
Lupin will bring to market a generic version of Lumigan solution, the company announced.
NPA renewed its call to the New York Attorney General to produce the scientific evidence behind that office's recall request of herbal supplements.
Kim Coalter, a staffer for Rep. Thad Cochran, R-Miss., toured Fred's Super Dollar pharmacy in Mississippi last week.
The recently introduced Ensuring Patient Access and Effective Drug Enforcement Act of 2015 receives support from the National Association of Chain Drug Stores.
CRN files second amicus brief challenging FTC "rigid standard" in evaluating supplement claims.
Proposed New York legislation could mean big changes for some beauty brands.
The Food and Drug Administration has approved Lenvima (lenvatinib) for the treatment of differentiated thyroid cancer.
In response to the New York Attorney General’s recent recall of herbal supplements from four major retailers, the Council for Responsible Nutrition has assembled a microsite for consumers.